News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
304,461 Results
Type
Article (8410)
Company Profile (103)
Press Release (295948)
Section
Business (105608)
Career Advice (635)
Deals (18379)
Drug Delivery (20)
Drug Development (31868)
Employer Resources (42)
FDA (4728)
Job Trends (5812)
News (160513)
Policy (10177)
Tag
Academia (527)
Alliances (22535)
Alzheimer's disease (435)
Approvals (4728)
Artificial intelligence (51)
Bankruptcy (124)
Best Places to Work (4418)
Biotechnology (100)
Breast cancer (84)
Cancer (611)
Career advice (553)
CAR-T (48)
Cell therapy (164)
Clinical research (25975)
Collaboration (261)
Compensation (153)
COVID-19 (649)
C-suite (94)
Data (676)
Diabetes (59)
Diagnostics (2452)
Earnings (45356)
Employer resources (43)
Events (53485)
Executive appointments (326)
FDA (5010)
Funding (252)
Gene therapy (77)
GLP-1 (169)
Government (678)
Healthcare (5914)
Infectious disease (681)
Inflammatory bowel disease (58)
Interviews (68)
IPO (9267)
Job creations (1591)
Job search strategy (512)
Layoffs (121)
Legal (2783)
Lung cancer (54)
Lymphoma (44)
Manufacturing (93)
Medical device (4075)
Medtech (4076)
Mergers & acquisitions (9314)
Metabolic disorders (158)
Neuroscience (575)
NextGen: Class of 2025 (2246)
Non-profit (918)
Northern California (1045)
Obesity (83)
Opinion (62)
Parkinson's disease (43)
People (32983)
Phase I (8823)
Phase II (11740)
Phase III (7847)
Pipeline (384)
Postmarket research (751)
Preclinical (3648)
Press Release (72)
Radiopharmaceuticals (137)
Rare diseases (102)
Real estate (2863)
Regulatory (7150)
Research institute (532)
Resumes & cover letters (88)
Southern California (866)
Startups (1685)
United States (8369)
Vaccines (85)
Date
Today (22)
Last 7 days (207)
Last 30 days (1013)
Last 365 days (16986)
2025 (971)
2024 (17209)
2023 (19657)
2022 (26037)
2021 (27324)
2020 (24229)
2019 (17579)
2018 (13597)
2017 (14002)
2016 (13026)
2015 (16257)
2014 (12821)
2013 (10431)
2012 (11334)
2011 (12050)
2010 (11620)
Location
Africa (282)
Arizona (67)
Asia (16976)
Australia (3102)
California (2285)
Canada (842)
China (117)
Colorado (74)
Connecticut (95)
Europe (36716)
Florida (260)
Illinois (174)
Indiana (108)
Japan (49)
Maryland (286)
Massachusetts (1839)
Michigan (127)
Minnesota (162)
New Jersey (559)
New York (596)
North Carolina (419)
Northern California (1045)
Ohio (66)
Pennsylvania (482)
South America (427)
Southern California (866)
Texas (274)
Utah (52)
Washington State (316)
304,461 Results for "generex biotechnology corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adnexus Biotechnologies Inc. Announces a Merger Agreement to Acquire Sanctum Therapeutics Corporation
November 6, 2024
·
5 min read
Business
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the first quarter ended March 31, 2024.
May 2, 2024
·
19 min read
Press Releases
Vir Biotechnology Reports Third Quarter 2024 Financial Results and Provides Corporate Update
October 31, 2024
·
17 min read
Business
CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics, today announced results for the first quarter ended 2024 and provided a corporate update.
May 29, 2024
·
18 min read
Press Releases
Adverum Biotechnologies Reports Third Quarter 2024 Financial Results, Provides Corporate Highlights and Updates Anticipated Milestones
November 4, 2024
·
8 min read
Layoffs
Sana Biotechnology Will Lay Off Employees as It Shifts Pipeline
About a year after cutting staff by 29%, Sana Biotechnology will trim its workforce as it increases investment in its type 1 diabetes program and looks to extend its cash runway.
November 5, 2024
·
1 min read
·
Angela Gabriel
Business
Generex Biotechnology Corporation Subsidiary, Olaregen Therapeutix Announces its Malaysian Distribution Partner, Nexgen Medical
Generex Biotechnology Corporation announced in May that the company has executed a Distribution Agreement with Nexgen Medical Sdn Bhd, Inc.
July 26, 2021
·
4 min read
Press Releases
Solid Biosciences Added to the Nasdaq Biotechnology Index
December 24, 2024
·
1 min read
Press Releases
Mesoblast to be Added to Nasdaq Biotechnology Index
December 19, 2024
·
5 min read
Press Releases
MAIA Biotechnology to Present at Biotech Showcase 2025
January 10, 2025
·
5 min read
1 of 30,447
Next
